To compare screen-film mammography with digital mammography in a breast cancer screening program, with a focus on the clinical relevance of detected cancers.
A total of 1 198 493 screening examinations were performed between 2003 and 2007. Recall was indicated in 18 896 cases (screen-film mammography: 2.6% at initial examinations, 1.3% at subsequent examinations; digital mammography: 4.4% at initial examinations, 2.1% at subsequent examinations; P , .001 for both). Breast cancer was diagnosed in 6410 women (detection rate per 1000 women with screen-film mammography: 5.6 at initial examinations, 5.2 at subsequent examinations; detection rate per 1000 women with digital mammography: 6.8 at initial examinations, 6.1 at subsequent examinations; P = .02 and P , .001, respectively). Digital mammography depicted significantly more ductal carcinoma in situ (DCIS) lesions, irrespective of screening round. Invasive carcinoma was detected significantly more often in subsequent examinations, particularly when associated with microcalcifications (P = .047). The distribution of the histopathologic differentiation grades for DCIS and invasive carcinoma were similar with both modalities. However, with digital mammography more high-grade DCIS lesions were detected at subsequent examinations (P = .013).
Conclusion:
In a population-based breast screening program, the performance of digital mammography in the detection of DCIS and invasive carcinoma was substantially better than that of screenfilm mammography. There is no sign of an increase in detection of low-grade DCIS lesions-indicative of possible overdiagnosis-with digital breast cancer screening. Rather, digital mammography appears to add to the detection of high-grade DCIS.
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Bluekens et al increase in DCIS detection, it is uncertain whether this favorable distribution of subtypes in screening-detected DCIS still holds. To our knowledge, detailed data concerning the pathologic characteristics of both in situ and invasive cancers detected at digital mammography screening have not yet been published. The aim of our large observational study was to compare screen-film mammography and digital mammography in a breast cancer screening program, with a focus on the clinical relevance of cancers.
Materials and Methods
The study was approved by a medical ethics review board. To comply with privacy regulations, all women signed a general informed consent form permitting the use of data for evaluation and scientific research. Specific written informed consent for this study was not required.
Setting
In anticipation of the nationwide transition from conventional to digital mammography in the Dutch screening program, three pilot studies were set up in [2003] [2004] to test the quality of digital screening and the organizational consequences of implementation.
The results of one of these pilot studies have been used to analyze the screening performance of digital mammography and led to previous publications (10, 21) . The current observational study encompasses the results of all three digital of ductal carcinoma in situ (DCIS) in the years after the introduction of population-based screening (4-6) was the basis for this concern. However, the implementation of digital mammography in breast cancer screening seems to be associated with further increases in the incidence of DCIS. Large studies comparing screen-film mammography to digital mammography showed such an effect (7) (8) (9) (10) (11) , sparking the debate about overdiagnosis in breast cancer screening programs.
Some researchers state that DCIS, as a precursor of invasive breast cancer, is the ideal screening target (12) . Critics of breast cancer screening, on the other hand, often argue that high detection rates of DCIS represent overdiagnosis, claiming that many cases are biologically unimportant (13, 14) .
Such criticism, however, seems to be unfounded without data about the characteristics of the detected lesions. After all, DCIS is considered to be a heterogeneous disease with varying morphology and behavior, ranging from rather indolent lesions to aggressively growing DCIS with invasive components (15, 16) . To date, standardized analysis of nuclear grade and associated necrosis is used to classify DCIS according to biologic potential and separate it into three risk groups: low, intermediate, and high grade (17, 18) . Because highgrade DCIS is more aggressive and often associated with invasive disease, the detection of these lesions in screening is likely to be of great importance in the prevention of life-threatening invasive cancer (19) .
In population-based screening programs, most detected DCIS lesions are high grade (19, 20) . However, with the advent of digital mammography in breast screening and the associated T he ultimate goal of screening mammography is to reduce the stage at which cancers are detected and treated, resulting in improved survival. With this ambition, population-based breast cancer screening was initiated in the Netherlands in 1989. In the years that followed, the Dutch screening program has proved to be successful (1) . Compared with data from the years just before the start of the nationwide screening, breast cancer mortality rates in women aged 55-74 years decreased substantially after 1997, reaching a low of 31% in 2009 (2)-an effect similar to that in other countries in Western Europe and North America (3).
Despite this distinct success, concerns have been raised about possible harms of mammography screening programs-in particular the overdiagnosis of breast cancer; that is, the diagnosis of cancer that, if left undetected and therefore untreated, would never have surfaced clinically in the person's lifetime. The large increase in the incidence 
Data Collection
Study data were collected from the database of the national breast cancer screening program, which included radiology reports and pathologic tumor characteristics and staging data. Radiologic abnormalities were classified as a mass, a mass with calcifications, microcalcifications only, or other (eg, architectural distortion and asymmetry). In one of the pilot studies, part of the radiology reports from the screen-film mammography group was not stored electronically. For the same reason, a small part of the radiologic digital mammography data was missing as well. Because these data could not be retrieved otherwise, we compared the distribution of radiologic features for the screen-film mammography group, both including and excluding the data from this pilot study, and found them to be remarkably similar. We therefore believe the missing data to be random and included the pilot study's data in the overall analysis.
The source of data about pathologic tumor characteristics was the original pathology report. Central pathologic review was not carried out. Pathologic characteristics of two pilot studies could be assembled from the screening database complemented by data from PALGA, the nationwide network and archive of pathology reports. One pilot region, however, was not connected to PALGA. Therefore, detailed pathology data had to be extracted from reports obtained from the individual pathology laboratories. To make this practically feasible, we chose to retrieve the data for all digital mammography cases and a random sample of the screen-film mammography cases (equal in size to the number of digital mammography cases). The sample of screen-film mammography cases was appropriately weighted by initial and subsequent examinations. Histologic type and grade of the tumors were recorded. In situ carcinomas were classified on the basis of nuclear grade and necrosis (17, 18) , whereas invasive imaging, reading, and recall for diagnostic work-up.
Conventional images were acquired with one of five different systems: GE 600 and 800T (GE Healthcare, Buc, France), Instrumentarium Alpha RT (Instrumentarium, Tuusula, Finland), Planmed Nuance (Planmed, Helsinki, Finland)-all of which used the Min-R 2000/Min-R 2250 screen-film combination (Kodak, Rochester, NY)-and Mammomat 3000 (Siemens, Erlangen, Germany), which used the Agfa HDR/MR Detail-R screen-film combination (Agfa-Gevaert, Mortsel, Belgium). Three different systems were used to acquire digital images: Lorad Selenia (Hologic, Danbury, Conn), Embrace DM1000 (Agfa-Gevaert), both of which used a 70-mm pixel size and a 24 3 29-cm field of view, and Lorad M-IV (Hologic) with a Profect CS reader and HR-BD screens (Fuji, Tokyo, Japan), which used a 50-mm pixel size and 18 3 24-cm and 24 3 30-cm fields of view.
For initial screening examinations, mediolateral oblique and craniocaudal views were obtained. The standard subsequent examination consisted of mediolateral oblique views only. A craniocaudal view was added when indicated (in 40%-50% of cases) by using criteria based on breast density and visible abnormality. One screening center, however, routinely obtained both views in first as well as subsequent screening examinations. In case of a subsequent screening examination, previously obtained mammograms were available for comparison at all times in all three screening centers. Computer-aided diagnosis was optional in one of the screening centers, as described in our previous report (10) .
Only certified and well-trained radiologists, who read 3000-5000 screening mammograms per year, performed the readings throughout the study period. Two radiologists read and rated the images independently. According to the current Dutch screening protocol, recall was indicated in cases of incomplete examination (Breast Imaging Reporting and Data System [BI-RADS] score 0) or suspicious findings mammography pilot studies conducted from October 2003 to December 2007 at the screening centers of Preventicon (Utrecht, the Netherlands), SBBZWN (Rotterdam, the Netherlands), and BBNN (Groningen, the Netherlands).
At the start of the pilot studies, digital mammography was introduced at each participating center by replacing at least one of the conventional units with a digital mammography system. All other conventional units were kept operational. The pilot studies were part of the national screening program in which all women aged 50-75 years receive a personal invitation to participate in screening every 2 years. Women are invited according to postal code and assigned to the nearest screening center. It is not possible for a woman to self-select her screening location. The screening program specifically targets asymptomatic women. The technicians are instructed and trained not to screen symptomatic women but to refer them to their general practitioners instead. Details concerning the Dutch screening program have been reported previously (22, 23) .
Participants
Between October 2003 and December 2007, all women attending the screening program at the participating centers were included in the study. If both modalities were present at the same screening location, assignment of women to digital mammography or screen-film mammography was based on the availability of the units when participants presented to the screening center. However, women who had previously undergone digital screening mammography were always offered digital mammography. In other cases, the assigned screening location determined the modality used.
All women invited for screening were informed in writing about the possibility of undergoing digital mammography. Refusing digital mammography for any reason did not have any consequences for screening participation and hardly ever occurred.
Procedures
The three screening centers worked independently and were responsible for A total of 15 238 women in the screen-film mammography group and 3658 women in the digital mammography group were recalled. Overall rates are not presented because an imbalance in the number of initial and subsequent examinations between both groups might create a bias. Recall rates were lower for screen-film mammography (2.6% for initial examinations, 1.3% for subsequent examinations) than for digital mammography (4.4% for initial examinations, 2.1% for subsequent examinations), and both differed significantly (P , .001) ( Table 1) .
Significantly more cancers were detected with digital mammography than with screen-film mammography, both for initial (P = .022) and subsequent (P , .001) screening examinations. For initial screening examinations, the detection rate per 1000 women was 5.6 with screen-film mammography and 6.8 with digital mammography. The difference in detection for subsequent screening examinations was also in favor of digital mammography, with respective rates of 5.2 and 6.1 per 1000 women.
The positive predictive value of recall was significantly lower for digital mammography than for screen-film mammography in both initial (15.6% vs 21.7%, respectively) and subsequent (29.6% vs 39.8%, respectively) screening examinations.
The proportion of lesions recalled on the basis of microcalcifications was significantly higher in the digital mammography group, with relatively fewer recalls based on mammographic masses (Table 2) . With conventional mammography, 19 .6% of all recalled lesions were based on microcalcifications withoutan associated density, whereas with digital bias caused by any imbalance in the number of initial and subsequent examinations between both groups.
Software was used for data management and analysis (SPSS, version 16.0 for Windows; SPSS, Chicago, Ill). Descriptive statistics were applied to explore the radiologic and pathologic characteristics of the lesions. Means were compared with an independent two-sample t test, whereas categorical variables were compared by using the Pearson x 2 test. P  .05 was considered indicative of a statistically significant difference.
Results
During the study period, 1 198 493 screening examinations were performed, which consisted of 1 045 978 screen-film mammography examinations (87.3%) and 152 515 digital mammography examinations (12.7%). Recall was indicated in 18 896 cases.
The mean age of recalled women at the time of the screening examination was 60.5 years for the screen-film mammography group and 59.3 years for the digital mammography group (P , .001). The mean age of women diagnosed with cancer was also lower in the digital carcinoma was classified on the basis of the Bloom and Richardson grading system modified by Elston and Ellis, all according to the World Health Organization classification system (24) . Staging data were recorded according to the TNM classification system developed by the International Union against Cancer (25) . In addition to separate T and N staging, two categories were created: T1N0 (small tumors without lymph node involvement) and .T1N0 (tumors .20 mm and/or those with lymph node involvement).
Statistical Analysis
Groups were compared for baseline characteristics such as age and screening interval. Screening intervals longer than 36 months were not taken into account because they were indicative of a missed screening round. We compared the two screening modalities with respect to breast cancer detection rate, recall rate, and positive predictive value for recall. Furthermore, differences in radiologic and pathologic characteristics of detected cancers were evaluated. Study results were evaluated separately for initial and subsequent screening examinations, thereby avoiding possible 
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Discussion
Results of our study showed that digital mammography is superior to screenfilm mammography in the screening setting in the early detection of clinically relevant cancers. Similar to what was found in other studies, the sensitivity of digital mammography was higher than that of screen-film mammography (8) (9) (10) 26) . More DCIS and invasive ductal carcinomas were detected with digital screening, the latter particularly when associated with microcalcifications. Therefore, the enhanced depiction of microcalcifications on digital images has most likely added to its higher (compared with 50.5% at conventional screening). High-grade DCIS lesions most often manifested as microcalcifications (90.0%). The overall distribution of the subtypes of invasive carcinoma was similar for both modalities (P = .122). In screening-detected invasive carcinoma, the moderately differentiated type (grade 2) was most frequent. The proportion of well-differentiated grade 1 invasive carcinoma was higher with digital mammography than with screen-film mammography (33.2% vs 29.7%, respectively) owing to the detection of significantly more grade 1 lesions in initial screening examinations (P , .001, Table 5 ). mammography 31.1% were based on microcalcifications alone.
Overall, a mass with microcalcifications was the radiologic feature with the highest positive predictive value for recall. With digital mammography, 48.1% were positive at diagnostic work-up, of which 86.3% concerned invasive carcinoma and 13.7% DCIS. Conversely, approximately one-fourth of recalled masses only or microcalcifications only were true positive (24.6% and 23.3%, respectively).
The detection of invasive carcinoma based on masses associated with microcalcifications was significantly better with digital mammography than with screenfilm mammography (P = .047). The detection of DCIS on the basis of microcalcifications tended to be better as well.
With digital mammography, in both initial and subsequent examinations, significantly more DCIS was detected (P = .002 and P , .001, respectively). In addition, relatively more invasive cancers were detected with digital mammography, but the difference was only significant for initial screening examinations (P , .001) ( Table 3 ). This higher detection of invasive cancers was completely accounted for by ductal carcinoma (P = .010), whereas the detection of lobular carcinoma and other subtypes was similar for both modalities (P = .527 and P = .105, respectively). Table 4 shows that most invasive cancers were small and nonadvanced, as judged by the proportion classified as T1N0. In this category, marginally more cancers were detected with digital mammography than with screen-film mammography (63.6% vs 61.7%, respectively; P = .347). In general, tumor stages were comparable.
Overall, the histopathologic grade distribution of DCIS did not differ significantly between the two modalities (P = .105). The share of low-grade (grade 1) DCIS was the same for both screening modalities (14.4%). The relative amount of high-grade DCIS was higher with digital mammography, primarily in subsequent screening examinations (P = .013, Table 5 ). The poorly differentiated type of DCIS (grade 3) occurred most often and accounted for 58.5% of all digitally detected in situ carcinomas Note.
-Missing values (positive findings without a specified diagnosis) were as follows: SBBZWN screening center: 0.5% screen-film mammography, 0.8% digital mammography; BBNN screening center: 0.2% screen-film mammography, 0% digital mammography; Preventicon screening center: 0.6% screen-film mammography, 0.6% digital mammography.
* Data are numbers of women. Numbers in parentheses are percentages. † Data are numbers of women. Numbers in parentheses are rates per 1000 women screened. detection performance. The histologic profile of these cancers, however, did not differ between the two screening modalities. Consistent with our previous work (10) as well as with other studies evaluating screening programs (8, 26, 27) , we found recall rates to be higher with digital mammography. This in turn led to lower positive predictive values of recall in initial and subsequent screening examinations. It is noteworthy, however, that the recall rates might be slightly overestimated because calculations were based on the complete study period, including the first months after the introduction of digital mammography-which are typically characterized by disproportionately high rates of recall (21) . Nevertheless, the recall rates remain relatively low in comparison to those of other breast cancer screening programs. Considering the work by Otten et al (28) , the high recall rates might have had a positive effect on cancer detection at digital mammography, but it is very unlikely that the high detection rates seen with digital mammography in our study were caused by this effect alone.
BREAST IMAGING:
The aim of screening is not to detect cancer as such, although that is its mechanism: The point of screening is to prevent tumor progression to disseminating, metastatic cancers (29) . Hence, depending on the biologic potential of cancers, early detection is only beneficial as long as it contributes to a decrease in cancer mortality and morbidity. All other diagnoses of malignancies could be termed overdiagnosis, which is the diagnosis of cancer that, if left undetected and therefore untreated, would never have surfaced clinically in a person's lifetime.
Overdiagnosis is an inevitable side effect of every screening program. In breast cancer screening, it is accepted because the benefits clearly outweigh the harms (30, 31) . However, overdiagnosis continues to be cited by critics of screening who assume that with the introduction of digital mammography in screening even more clinically unimportant cancers will be detected (32) .
Potential candidates for overdiagnosis are present predominantly in the group of noninvasive cancers (DCIS), typically
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Bluekens et al rate, whereas the U.S. approach focuses more on a high detection rate, resulting in higher recall and false-positive rates. This is also reflected in the types of lesions that are detected (eg, higher detection of low-grade DCIS) (37) . These differences should be kept in mind when comparing results among the Dutch, U.S., and other screening programs. This large multicenter study, similar to previous studies, showed digital mammography to have a significantly better detection performance than screen-film mammography in population-based breast cancer screening. This gain is largely due to enhanced depiction of microcalcifications, resulting in improved detection of both DCIS and invasive carcinoma. Although, as with screen-film mammography, digitally detected DCIS predominantly consisted of high-grade lesions, the detection of low-grade DCIS in digital screening remained fairly uncommon. The overall distribution of subtypes according to differentiation grade did not change significantly with use of digital mammography. This finding suggests that presumed overdiagnosis does not increase with the use of digital mammography in breast cancer screening programs. Recently, other researchers have reported similar results (35, 36) .
Our study has some limitations. Because digital mammography was used in a pilot setting, most of the screening examinations were performed with conventional units. This was reflected in our study population, where screenfilm mammography represented 87.3% of the cases. Because the study was not to interfere with the ongoing screening program, matching all baseline characteristics in the three digital pilot studies was not feasible. Regional differences in screening setup were foreseen and accepted because this study had to be purely observational to evaluate the digital program in daily practice. Even though the results for each screening center showed similar trends, this siteto-site variability might have had an influence on screening performance. It is unlikely, however, that this had any effect on the distribution of detected cancer subtypes. Another drawback is the missing radiology data for screenfilm examinations in one pilot study. However, because we found the results to be quite similar whether including or excluding the data from this pilot study, we felt reassured that the missing values represent a random sample and do not compromise the validity of our study. The source of data on pathologic tumor characteristics was the original pathology report. No central pathologic review was carried out, which may influence the consistency of histologic grading. One pilot region was not connected to the nationwide network and archive of pathology reports. Therefore, detailed pathology data had to be extracted from reports obtained from the individual pathology laboratories. To make this practically feasible, we chose to retrieve the data for all digital mammography cases and an equal random sample of the screen-film mammography cases.
The setup of the Dutch screening program differs in some aspects (eg, number of views, screening interval, and low recall rate) from other screening programs such as that in the United States. For the Dutch program, the focus is on a financially and socially acceptable balance between detection, recall, and false-positive of the well-differentiated, low-grade type. Although all grades have potential to progress and become invasive (33), the development of low-grade DCIS can extend over more than 3 decades (34), whereas high-grade DCIS is associated with far more rapid cancer invasion (16) .
Although the biologic indolence of low-grade DCIS makes detection of this subtype less important in mass screening, the detection of high-grade DCIS might contribute to mortality reduction by preventing development of lifethreatening invasive carcinoma.
We did not find a significant difference in the overall distribution of differentiation subtypes of both DCIS and invasive cancers detected with digital mammography and screen-film mammography. This similarity indicates that the increased detection with digital mammography covers the complete spectrum of breast cancer. According to our data, there is no sign of a disproportionate increase in low-grade DCIS lesions-indicative of possible overdiagnosis-with the transition to digital mammography in breast cancer screening.
When observed as separate entities, low-grade DCIS accounted for 14.4% of all DCIS cases with both modalities in our study. This means that although detection rates increased with digital mammography, still only 3.0% of all digital screening-detected cancers involved low-grade DCIS. Consistent with previous studies, screening-detected DCIS predominantly concerned high-grade lesions (5, 19) . We observed the detection of high-grade DCIS to be higher with digital mammography than with screenfilm mammography (58.5% vs 50.5%, respectively), particularly as a result of a significantly better detection at subsequent screening examinations. Although the overall distribution did not change significantly, this might imply a more favorable subtype profile of screening-detected DCIS with digital mammography.
Because cancers associated with microcalcifications are more often detected with digital mammography, our findings suggest that the improvement in detection performance with digital mammography is primarily due to better depiction of microcalcifications.
